A Phase III, Multi-center, Open-label, Randomized Study to Assess the Efficacy and Safety of Org 37462 Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for IVF or ICSI, Using a Long Protocol of Triptorelin as a Reference Treatment.
Phase of Trial: Phase III
Latest Information Update: 20 Dec 2014
At a glance
- Drugs Ganirelix (Primary) ; Chorionic gonadotropin; Recombinant follicle-stimulating hormone; Triptorelin
- Indications Infertility
- Focus Therapeutic Use
- Sponsors Organon
- 27 Jan 2010 Actual end date changed from Nov 2008 to Dec 2008 as reported by ClinicalTrials.gov.
- 25 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History